RPRX up +10.50% percent Today $RPRX High is at 10.53 and the Low 9.63 with current volume of 425,142.
Recent News posted below.
Repros Therapeutics Inc RPRX other info.
http://investorshangout.com/Repros-Therapeuti...PRX-55325/
RPRX Repros Therapeutics Inc Recent Headline News
Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CLUB: 5.88 (-0.09), HYGS: 14.52 (-0.71), KNDI: 13.38 (-1.37), MCEP: 16.76 (+0.23), HYG.TO: 16.53 (-0.65), RPRX: 10.27 (+0.84), SHLD: 38.16 (+0.40), PAA.TO: 10.86 (+0.16), PAAS: 9.55 (+0.08), REXX: 7.27 (-0.28), AKBA: 11.42 (-0.79), GCBC: 25.32 (-2.40), ASEI: 44.52 (-0.25), MTEX: 23.05 (+0.27), PLNR: 6.90 (-0.25)
Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:20PM CST
Shares of Repros Therapeutics (RPRX) shot up 56.9% following a successful meeting with the FDA regarding Androxal.
BIIB: 317.81 (-3.21), RPRX: 10.27 (+0.84), ABBV: 63.93 (+0.17), AMAG: 34.65 (-0.28)
Repros Therapeutics posts 3Q loss
Automated Insights - Mon Nov 10, 8:13AM CST
WOODLANDS, Texas (AP) _ Repros Therapeutics Inc. (RPRX) on Monday reported a loss of $7.4 million, or 32 cents per share, in its third quarter.
RPRX: 10.27 (+0.84)
Repros Therapeutics beats by $0.07
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:11AM CST
RPRX: 10.27 (+0.84)
Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results
GlobeNewswire - Mon Nov 10, 8:00AM CST
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the third quarter ended September 30, 2014.
RPRX: 10.27 (+0.84)
Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 1.20 (+0.07), AMSC: 1.01 (-0.07), RPRX: 10.27 (+0.84), SHLD: 38.16 (+0.40), STAY: 17.62 (-0.01)
Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 11:52AM CST
ROKA: 3.53 (-0.06), NES: 7.98 (-0.19), FNGN: 32.32 (+0.04), FIVN: 4.97 (+0.06), MSON: 12.17 (+0.17), SLXP: 96.04 (+0.49), SUMR: 2.87 (+0.07), RPRX: 10.27 (+0.84), QTWO: 18.00 (+0.09), EV: 41.13 (-0.27), SHLD: 38.16 (+0.40), STAY: 17.62 (-0.01), PSIX: 68.30 (-1.55), BORN: 1.49 (-0.01), URRE: 2.26 (-0.23), ECOM: 18.58 (-0.18), ICPT: 155.87 (-7.09), SAEX: 3.88 (-0.14), VPCO: 1.88 (+0.31), SZYM: 3.47 (-0.05)
Repros Therapeutics (RPRX) Stock Skyrockets After Meeting with FDA About Androxal
at The Street - Fri Nov 07, 10:07AM CST
Shares of Repros Therapeutics (RPRX) soared in morning trading Friday after the biopharmaceutical company held what it called a "constructive meeting" with the FDA regarding its testosterone-boosting drug Androxal.
RPRX: 10.27 (+0.84)
Repros jumps after FDA meeting on Androxal NDA
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 9:20AM CST
RPRX: 10.27 (+0.84)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST
BEBE: 2.43 (-0.04), ANET: 77.37 (+0.13), TKMR: 16.43 (+0.33), ORBC: 6.40 (-0.17), MDRX: 12.38 (+0.43), RMTI: 11.02 (-0.22), CTIC: 2.18 (unch), SHLD: 38.16 (+0.40), UBNT: 28.51 (-0.49), RIG: 26.27 (-0.81), KGC: 2.53 (+0.07), APT: 2.87 (-0.13), ANF: 29.17 (-0.18), MITK: 3.49 (-0.17), ZNGA: 2.80 (-0.01), CNET: 2.08 (-0.07), KING: 15.43 (+1.40), NETE: 1.38 (-0.02), SLXP: 96.04 (+0.49), RPRX: 10.27 (+0.84), NADL: 4.30 (-0.64), PGNX: 6.64 (+0.03), AVNR: 13.27 (+0.09), FSLR: 47.93 (-1.66), DVA: 76.83 (+0.11), NDLS: 23.72 (-0.42), ICPT: 155.87 (-7.09), AGIO: 86.22 (-0.65), PLNR: 6.90 (-0.25)
Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing
GlobeNewswire - Thu Nov 06, 3:21PM CST
-- No New Clinical Studies Requested
RPRX: 10.27 (+0.84)
Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:12PM CST
Repros Therapeutics Inc. (RPRX) has an earnings ESP of 0.00% and a Zacks Rank #4 (Sell).
MNK: 87.30 (-5.69), PBH: 31.65 (-0.14), RPRX: 10.27 (+0.84), HSP: 57.79 (-0.30)
63.7% Return Seen to Date on SmarTrend Repros Therapeutics Call (RPRX)
Comtex SmarTrend(R) - Mon Nov 03, 10:56AM CST
SmarTrend identified a Downtrend for Repros Therapeutics (NASDAQ:RPRX) on September 4th, 2014 at $17.86. In approximately 2 months, Repros Therapeutics has returned 63.72% as of today's recent price of $6.48.
RPRX: 10.27 (+0.84)
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings
PR Newswire - Mon Nov 03, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Repros Therapeutics Inc. (NASDAQ: RPRX), Nektar Therapeutics (NASDAQ: NKTR), Akorn Inc. (NASDAQ: AKRX), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 31, 2014, the NASDAQ Composite ended at 4,630.74, up 1.41%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 17,390.52, and the S&P 500 closed at 2,018.05, up 1.17%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.85, up 0.51%, with the index also advancing 10.60% in the previous three months. Register for your complimentary reports on these five stocks at:
ACRX: 7.04 (+0.09), PTX: 11.00 (-0.05), AKRX: 37.27 (+1.84), RPRX: 10.27 (+0.84), NKTR: 13.91 (-0.06)
Repros to Webcast Investor and Analyst Day on October 31st
GlobeNewswire - Mon Oct 27, 3:01PM CDT
Repros Therapeutics Inc.(Nasdaq:RPRX) today announced that it will host a live webcast of its Investor and Analyst Day that is being held in New York City on Friday, October 31, 2014 beginning at 7:30 a.m. Eastern Time.
RPRX: 10.27 (+0.84)
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 22, 10:18AM CDT
Will Amgen (AMGN) go the Abbott (ABT) way and split into two separate companies?
PCYC: 138.43 (+1.06), NPSP: 29.38 (+0.21), RPRX: 10.27 (+0.84), AMGN: 160.52 (-1.41), ABBV: 63.93 (+0.17), REGN: 399.26 (-1.85), CELG: 106.95 (-1.30)
Recent News posted below.
Repros Therapeutics Inc RPRX other info.
http://investorshangout.com/Repros-Therapeuti...PRX-55325/
RPRX Repros Therapeutics Inc Recent Headline News
Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CLUB: 5.88 (-0.09), HYGS: 14.52 (-0.71), KNDI: 13.38 (-1.37), MCEP: 16.76 (+0.23), HYG.TO: 16.53 (-0.65), RPRX: 10.27 (+0.84), SHLD: 38.16 (+0.40), PAA.TO: 10.86 (+0.16), PAAS: 9.55 (+0.08), REXX: 7.27 (-0.28), AKBA: 11.42 (-0.79), GCBC: 25.32 (-2.40), ASEI: 44.52 (-0.25), MTEX: 23.05 (+0.27), PLNR: 6.90 (-0.25)
Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:20PM CST
Shares of Repros Therapeutics (RPRX) shot up 56.9% following a successful meeting with the FDA regarding Androxal.
BIIB: 317.81 (-3.21), RPRX: 10.27 (+0.84), ABBV: 63.93 (+0.17), AMAG: 34.65 (-0.28)
Repros Therapeutics posts 3Q loss
Automated Insights - Mon Nov 10, 8:13AM CST
WOODLANDS, Texas (AP) _ Repros Therapeutics Inc. (RPRX) on Monday reported a loss of $7.4 million, or 32 cents per share, in its third quarter.
RPRX: 10.27 (+0.84)
Repros Therapeutics beats by $0.07
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:11AM CST
RPRX: 10.27 (+0.84)
Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results
GlobeNewswire - Mon Nov 10, 8:00AM CST
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the third quarter ended September 30, 2014.
RPRX: 10.27 (+0.84)
Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 1.20 (+0.07), AMSC: 1.01 (-0.07), RPRX: 10.27 (+0.84), SHLD: 38.16 (+0.40), STAY: 17.62 (-0.01)
Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 11:52AM CST
ROKA: 3.53 (-0.06), NES: 7.98 (-0.19), FNGN: 32.32 (+0.04), FIVN: 4.97 (+0.06), MSON: 12.17 (+0.17), SLXP: 96.04 (+0.49), SUMR: 2.87 (+0.07), RPRX: 10.27 (+0.84), QTWO: 18.00 (+0.09), EV: 41.13 (-0.27), SHLD: 38.16 (+0.40), STAY: 17.62 (-0.01), PSIX: 68.30 (-1.55), BORN: 1.49 (-0.01), URRE: 2.26 (-0.23), ECOM: 18.58 (-0.18), ICPT: 155.87 (-7.09), SAEX: 3.88 (-0.14), VPCO: 1.88 (+0.31), SZYM: 3.47 (-0.05)
Repros Therapeutics (RPRX) Stock Skyrockets After Meeting with FDA About Androxal
at The Street - Fri Nov 07, 10:07AM CST
Shares of Repros Therapeutics (RPRX) soared in morning trading Friday after the biopharmaceutical company held what it called a "constructive meeting" with the FDA regarding its testosterone-boosting drug Androxal.
RPRX: 10.27 (+0.84)
Repros jumps after FDA meeting on Androxal NDA
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 9:20AM CST
RPRX: 10.27 (+0.84)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST
BEBE: 2.43 (-0.04), ANET: 77.37 (+0.13), TKMR: 16.43 (+0.33), ORBC: 6.40 (-0.17), MDRX: 12.38 (+0.43), RMTI: 11.02 (-0.22), CTIC: 2.18 (unch), SHLD: 38.16 (+0.40), UBNT: 28.51 (-0.49), RIG: 26.27 (-0.81), KGC: 2.53 (+0.07), APT: 2.87 (-0.13), ANF: 29.17 (-0.18), MITK: 3.49 (-0.17), ZNGA: 2.80 (-0.01), CNET: 2.08 (-0.07), KING: 15.43 (+1.40), NETE: 1.38 (-0.02), SLXP: 96.04 (+0.49), RPRX: 10.27 (+0.84), NADL: 4.30 (-0.64), PGNX: 6.64 (+0.03), AVNR: 13.27 (+0.09), FSLR: 47.93 (-1.66), DVA: 76.83 (+0.11), NDLS: 23.72 (-0.42), ICPT: 155.87 (-7.09), AGIO: 86.22 (-0.65), PLNR: 6.90 (-0.25)
Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing
GlobeNewswire - Thu Nov 06, 3:21PM CST
-- No New Clinical Studies Requested
RPRX: 10.27 (+0.84)
Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:12PM CST
Repros Therapeutics Inc. (RPRX) has an earnings ESP of 0.00% and a Zacks Rank #4 (Sell).
MNK: 87.30 (-5.69), PBH: 31.65 (-0.14), RPRX: 10.27 (+0.84), HSP: 57.79 (-0.30)
63.7% Return Seen to Date on SmarTrend Repros Therapeutics Call (RPRX)
Comtex SmarTrend(R) - Mon Nov 03, 10:56AM CST
SmarTrend identified a Downtrend for Repros Therapeutics (NASDAQ:RPRX) on September 4th, 2014 at $17.86. In approximately 2 months, Repros Therapeutics has returned 63.72% as of today's recent price of $6.48.
RPRX: 10.27 (+0.84)
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings
PR Newswire - Mon Nov 03, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Repros Therapeutics Inc. (NASDAQ: RPRX), Nektar Therapeutics (NASDAQ: NKTR), Akorn Inc. (NASDAQ: AKRX), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 31, 2014, the NASDAQ Composite ended at 4,630.74, up 1.41%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 17,390.52, and the S&P 500 closed at 2,018.05, up 1.17%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.85, up 0.51%, with the index also advancing 10.60% in the previous three months. Register for your complimentary reports on these five stocks at:
ACRX: 7.04 (+0.09), PTX: 11.00 (-0.05), AKRX: 37.27 (+1.84), RPRX: 10.27 (+0.84), NKTR: 13.91 (-0.06)
Repros to Webcast Investor and Analyst Day on October 31st
GlobeNewswire - Mon Oct 27, 3:01PM CDT
Repros Therapeutics Inc.(Nasdaq:RPRX) today announced that it will host a live webcast of its Investor and Analyst Day that is being held in New York City on Friday, October 31, 2014 beginning at 7:30 a.m. Eastern Time.
RPRX: 10.27 (+0.84)
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 22, 10:18AM CDT
Will Amgen (AMGN) go the Abbott (ABT) way and split into two separate companies?
PCYC: 138.43 (+1.06), NPSP: 29.38 (+0.21), RPRX: 10.27 (+0.84), AMGN: 160.52 (-1.41), ABBV: 63.93 (+0.17), REGN: 399.26 (-1.85), CELG: 106.95 (-1.30)
